Dexrazoxane cardioprotection

Chairs

Annelies M.C. Mavinkurve-Groothuis, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Saro Armenian, City of Hope National Medical Center, Duarte, United States

Coordinator

Esmée C. de Baat, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Elvira C. van Dalen, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

WG members

Matthew J. Ehrhardt, St. Jude Children’s Research Hospital, Memphis, United States
Frederike K. Engels, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Elizabeth A.M. Feijen, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Heynric B. Grotenhuis, University Medical Center Utrecht, Wilhelmina Children’s Hospital, Utrecht, the Netherlands
Livia Kapusta, Amalia Children’s Hospital, Radboud university medical center, Nijmegen, The Netherlands and Tel Aviv Sourasky Medical Centre, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Gertjan J.L. Kaspers, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Jan M. Leerink, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Amsterdam University Medical Center, Amsterdam, The Netherlands
Remy Merkx, Radboud university medical center, Nijmegen, The Netherlands
Luc Mertens, The Hospital for Sick Children, The University of Toronto, Toronto, Canada
Paul C. Nathan, The Hospital for Sick Children, The University of Toronto, Toronto, Canada
Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Wim J.E. Tissing, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Florent de Vathaire, Institut Gustave Roussy, Villejuif, France